![Kunwar Shailubhai](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Kunwar Shailubhai
Corporate Officer/Principal at
Baruch S. Blumberg Institute
Profile
Kunwar Shailubhai is the founder of Synergy Pharmaceuticals LLC, which was founded in 2001.
He held the position of Chief Scientific Officer & Executive VP from 2008 to 2017.
Currently, he is a Professor at Baruch S.
Blumberg Institute.
Dr. Shailubhai's former jobs include being a Non-Executive Director at OKYO Pharma Ltd. from 2017 to 2021, a Director at Active With Me, Inc., an Executive Director at Tiziana Life Sciences Ltd. (United Kingdom) in 2022, an Executive Director at Actavia Life Sciences, Inc. in 2020, and a Vice President-Drug Discovery at Callisto Pharmaceuticals, Inc. from 2001 to 2004.
He was also a Chief Scientific Officer at Pawfect Foods, Inc. and a Senior Vice President at Drug Discovery Facility from 2003 to 2008.
Additionally, he was an Assistant Professor at the University of Maryland and the Chief Executive & Scientific Officer at Tiziana Life Sciences Ltd. Dr. Shailubhai received an MBA degree from the University of Missouri in 2002 and a doctorate degree from the University of Baroda in 1984.
Kunwar Shailubhai active positions
| Companies | Position | Start |
|---|---|---|
Baruch S. Blumberg Institute
 Baruch S. Blumberg Institute The Baruch S. Blumberg Institute is a nonprofit translational research organization dedicated to curing hepatitis B and liver cancer. The non-profit company is based in Doylestown, PA. The institute conducts multidisciplinary research in virology, antiviral drug discovery, biopharmaceutics (including RNA and gene-editing therapeutics), precision medicine, cancer and regenerative medicine, and public health focused on eliminating health disparities related to hepatitis B. It operates within a collaborative ecosystem alongside the Hepatitis B Foundation and the Pennsylvania Biotechnology Center, and manages B+Labs, which provides wet lab and office space to support innovation and entrepreneurship in life sciences. The institute offers training programs such as summer internships, high school science enrichment, AP chemistry mentorships, and post-graduate education, and hosts a seminar series to promote scientific exchange and collaboration. It partners with academic institutions and patient communities to integrate research, education, and advocacy, and is supported by donor contributions to advance research, education, and public health efforts for hepatitis B, liver cancer, and related viral diseases. The company was founded by Timothy M. Block. | Corporate Officer/Principal | - |
Former positions of Kunwar Shailubhai
| Companies | Position | End |
|---|---|---|
| TIZIANA LIFE SCIENCES LTD | Chief Executive Officer | 2022-07-31 |
Tiziana Life Sciences Ltd. (United Kingdom)
 Tiziana Life Sciences Ltd. (United Kingdom) BiotechnologyHealth Technology Operates as a clinical stage biotechnology company that develops transformative therapies for neurodegenerative and neuroinflammatory | Chief Executive Officer | - |
| ACCM SCIE | Director/Board Member | 2022-06-19 |
| WEST AFRICAN MINERALS CORP | Director/Board Member | 2021-06-16 |
| ACTAVIA LIFE SCIENCES, INC. | Chief Executive Officer | 2020-02-05 |
Training of Kunwar Shailubhai
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
50
1st degree connections
14
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 14 |
|---|---|
Callisto Pharmaceuticals, Inc.
 Callisto Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Researches and develops novel therapeutics to treat cancer | Health Technology |
Pawfect Foods, Inc.
 Pawfect Foods, Inc. Specialty StoresRetail Trade Sells pet food via the internet | Retail Trade |
OKYO Pharma Ltd.
 OKYO Pharma Ltd. BiotechnologyHealth Technology Develops next-generation therapeutics to improve the lives of patients suffering from inflammatory eye diseases | Health Technology |
Active With Me, Inc.
 Active With Me, Inc. Miscellaneous Commercial ServicesCommercial Services Provides online resources that seamlessly offer travelers unique, relevant and user-friendly information on activity-based travel | Commercial Services |
University of Missouri
 University of Missouri Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Drug Discovery Facility
 Drug Discovery Facility Pharmaceuticals: MajorHealth Technology Provides research into drug-discovery processes | Health Technology |
University of Maryland
 University of Maryland Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of Baroda
 University of Baroda Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Synergy Pharmaceuticals LLC
 Synergy Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Develops drugs to treat gastrointestinal disorders and diseases | Health Technology |
Baruch S. Blumberg Institute
Baruch S. Blumberg Institute The Baruch S. Blumberg Institute is a nonprofit translational research organization dedicated to curing hepatitis B and liver cancer. The non-profit company is based in Doylestown, PA. The institute conducts multidisciplinary research in virology, antiviral drug discovery, biopharmaceutics (including RNA and gene-editing therapeutics), precision medicine, cancer and regenerative medicine, and public health focused on eliminating health disparities related to hepatitis B. It operates within a collaborative ecosystem alongside the Hepatitis B Foundation and the Pennsylvania Biotechnology Center, and manages B+Labs, which provides wet lab and office space to support innovation and entrepreneurship in life sciences. The institute offers training programs such as summer internships, high school science enrichment, AP chemistry mentorships, and post-graduate education, and hosts a seminar series to promote scientific exchange and collaboration. It partners with academic institutions and patient communities to integrate research, education, and advocacy, and is supported by donor contributions to advance research, education, and public health efforts for hepatitis B, liver cancer, and related viral diseases. The company was founded by Timothy M. Block. | |
Tiziana Life Sciences Ltd. (United Kingdom)
Tiziana Life Sciences Ltd. (United Kingdom) BiotechnologyHealth Technology Operates as a clinical stage biotechnology company that develops transformative therapies for neurodegenerative and neuroinflammatory | Health Technology |
Actavia Life Sciences, Inc.
 Actavia Life Sciences, Inc. Pharmaceuticals: MajorHealth Technology Develops pharmaceuticals | Health Technology |
AccuStem Sciences, Inc.
 AccuStem Sciences, Inc. Pharmaceuticals: MajorHealth Technology Manufactures genomics-based personalized medicines for breast cancer patients | Health Technology |
Tiziana Life Sciences Ltd.
 Tiziana Life Sciences Ltd. Pharmaceuticals: MajorHealth Technology Develops pharmaceuticals | Health Technology |
- Stock Market
- Insiders
- Kunwar Shailubhai
Choose MarketScreener 
